ARTICLE

FindCenter AddIcon

How Researchers and Advocates of Color Are Forging Their Own Paths in Psychedelic-Assisted Therapy

By Steph Yin — 2020

We’re seeing an explosion of medical research into psychedelics. Psilocybin, or shrooms, to treat major depressive disorder. Ayahuasca, a psychotropic plant medicine from the Amazon, and ibogaine, a potent hallucinogen from Africa, to treat addiction. LSD for anxiety.

Read on whyy.org

FindCenter Post-Image

We Can No Longer Ignore the Potential of Psychedelic Drugs to Treat Depression

At Imperial College we’ve been comparing psilocybin to conventional antidepressants—and the results are likely to be game-changing.

Article
Robin Carhart-Harris
2020
FindCenter AddIcon
FindCenter Post-Image

Magic Mushrooms Expand the Mind by Dampening Brain Activity

A new brain-scan study helps explain how psilocybin works—and why it holds promise as a treatment for depression, addiction and post-traumatic stress.

Article
Maia Szalavitz
2012
FindCenter AddIcon
FindCenter Post-Image

The Future of Psychedelic Medicine

This is an exciting time to be involved in psychedelic research. Medical researchers are rediscovering the possible benefits of responsible use of psychedelics in therapeutic settings.

Article
Amanda Feilding
2017
FindCenter AddIcon
FindCenter Post-Image

Interview with Albert Hofmann, the Man Who First Synthesized LSD

The late chemist Albert Hofmann discussed his psychedelic research on LSD in the July, 1976 issue of High Times.

Article
High Times
2020
FindCenter AddIcon

EXPLORE TOPIC

MDMA